Analysis of factors of treatment completion in DOTS health facilities in Metro Manila, Philippines: A case-control study

Kekkaku

Volumn 83, Issue 12, 2008, Pages 765-772

  Lagrada, Leizel P ^a   Uehara, Naruo ^b   Kawahara, Kazuo ^a  

^a Graduate School of Tokyo Medical and Dental University ^*  (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Case control; DOTS; Philippines; Public private mix; Treatment outcome

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COST BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH CARE FACILITY; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PHILIPPINES; POVERTY; QUESTIONNAIRE; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; TUBERCULOSIS; UNEMPLOYMENT;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH FACILITIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHILIPPINES; POVERTY; QUESTIONNAIRES; SEX FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; UNEMPLOYMENT;

EID: 61549113454     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. DOH. Philippine Health Statistics : Department of Health. Manila, Philippines, 2003.
2. Tupasi TE, Radhakrishna S, Rivera AB, et al. : The 1997 Nationwide Tuberculosis Prevalence Survey in the Philippines. Int J Tuberc Lung Dis. 1999 ; 3 : 471-477.
3. Clinical Practice Guidelines for the Diagnosis, Treatment, Prevention and Control of Tuberculosis in Adult Filipinos ; 2006 UPDATE. Manila, Philippines : Philippine Society for Microbiology and Infections Diseases, Philippine College of Chest Physicians, Philippine Coalition Against Tuberculosis, Philippine College of Physicians, Philippine College of Radiology, Philippine Academy of Family Physicians, Philippine College of Occupational Medicine, Department of Health, 2006.
4. WHO : Global tuberculosis control : surveillance, planning, financing WHO Report 2008 : World Health Organization, 2008.
5. DOH : National Tuberculosis Control Program : Cohort Report 2003-2005, 2005.
6. Auer C, Sarol J, Jr., Tanner M, et al. : Health seeking and perceived causes of tuberculosis among patients in Manila, Philippines. Trop Med Int Health. 2000 ; 5 : 648-656.
7. Tupasi TE, Radhakrishna S, Co VM, et al. : Bacillary disease and health seeking behavior among Filipinos with symptoms of tuberculosis : implications for control. Int J Tuberc Lung Dis. 2000 ; 4 : 1126-1132.
8. Mantala MJ : Public-private mix DOTS in the Philippines. Tuberculosis (Edinb). 2003 ; 83 : 173-176.
9. Portero JL, Rubio M : Private practitioners and tuberculosis control in the Philippines ; strangers when they meet? Trop Med Int Health. 2003 ; 8 : 329-335.
10. Wong J, Aldaba B, Gorra E, et al. : The Philippine Private Sector Drug Facility : A Need and Supply Situation Study. Pasig City : Philippine Tuberculosis Initiative for Private Sector Project, 2004.
11. NSCB : Explanatory Notes on the 2003 Poverty Estimates : National Statistical Coordination Board, 2005.
12. WHO : Global Tuberculosis Control : Surveillance, Planning, Financing WHO Report 2006 : World Health Organization, 2006.
13. Munro SA, Lewin SA, Smith HJ, et al. : Patient adherence to tuberculosis treatment : a systematic review of qualitative research. PLoS Med. 2007 ; 4 : e238.
14. Shargie EB, Lindtjorn B : DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia : a retrospective trend analysis. BMC Public Health. 2005 ; 5 : 62.
15. Balbay O, Annakkaya AN, Arbak P, et al. : Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis. 2005 ; 58 : 152-158.
16. Bam TS, Gunneberg C, Chamroonsawasdi K, et al. : Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis. 2006 ; 10 : 270-276.
17. Mishra P, Hansen EH, Sabroe S, et al. : Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Patient Educ Couns. 2006 ; 63 : 29-37.
18. O'Boyle SJ, Power JJ, Ibrahim MY, et al. : Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002 ; 6 : 307-312.
19. Yew WW : Directly observed therapy, short-course: the best way to prevent multidrug-resistant tuberculosis. Chemotherapy. 1999 ; 45 Suppl 2 : 26-33.
20. Rodger AJ, Toole M, Lalnuntluangi B, et al. : DOTS-based tuberculosis treatment and control during civil conflict and an HIV epidemic, Churachandpur District, India. Bull World Health Organ. 2002 ; 80 : 451-456.
21. Khan MA, Walley JD, Witter SN, et al. : Tuberculosis patient adherence to direct observation : results of a social study in Pakistan. Health Policy Plan. 2005 ; 20 : 354-365.
22. Radilla-Chavez P, Laniado-Laborin R : Results of directly observed treatment for tuberculosis in Ensenada, Mexico ; not all DOTS programs are created equally. Int J Tuberc Lung Dis. 2007 ; 11 : 289-292.
23. DOH: Comprehensive and Unified Policy for TB Control in the Philippines. Manila : Department of Health and Philippine Coalition against Tuberculosis, 2003.
24. WHO : Adherence to Long-Term Therapies : Evidence for Action. Geneva : World Health Organization, 2003.
25. DOH : Manual of Procedures National Tuberculosis Control Program : Department of Health, Manila, Philippines, 2001.
26. Davidson H, Schluger NW, Feldman PH, et al. : The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Int J Tuberc Lung Dis. 2000 ; 4 : 860-865.
27. Bock NN, Sales RM, Rogers T, et al.: A spoonful of sugar... : improving adherence to tuberculosis treatment using financial incentives. Int J Tuberc Lung Dis. 2001 ; 5 : 96-98.
28. Belo MT, Selig L, Luiz RR, et al.: Choosing incentives to stimulate tuberculosis treatment compliance in a poor county in Rio de Janeiro state, Brazil. Med Sci Monit. 2006 ; 12 : PH1-5.